{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T23:54:46Z","timestamp":1788652486575,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/7\/1090\/2013-RHN"],"award-info":[{"award-number":["5\/7\/1090\/2013-RHN"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00467-025-07085-6","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T16:33:30Z","timestamp":1764606810000},"page":"1055-1060","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence and types of anti-neutrophil cytoplasmic antibodies in patients with nephrotic syndrome treated with levamisole"],"prefix":"10.1007","volume":"41","author":[{"given":"Puneet","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineeta","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Hari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-684X","authenticated-orcid":false,"given":"Arvind","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"7085_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","volume":"38","author":"A Trautmann","year":"2023","unstructured":"Trautmann A, Boyer O, Hodson E, Bagga A, Gipson DS, Samuel S, Wetzels J, Alhasan K, Banerjee S, Bhimma R, Bonilla-Felix M, Cano F, Christian M, Hahn D, Kang HG, Nakanishi K, Safouh H, Trachtman H, Xu H, Cook W, Vivarelli M, Haffner D, International Pediatric Nephrology Association (2023) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 38:877\u2013919","journal-title":"Pediatr Nephrol"},{"key":"7085_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13312-021-2217-3","volume":"58","author":"A Sinha","year":"2021","unstructured":"Sinha A, Bagga A, Banerjee S, Mishra K, Mehta A, Agarwal I, Uthup S, Saha A, Mishra OP, Expert Group of Indian Society of Pediatric Nephrology (2021) Steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr 58:461\u2013481","journal-title":"Indian Pediatr"},{"key":"7085_CR3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.kint.2024.01.028","volume":"105","author":"A Sinha","year":"2024","unstructured":"Sinha A, Devi KG, Kalra S, Mani K, Hari P, Bagga A (2024) An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome. Kidney Int 105:1113\u20131123","journal-title":"Kidney Int"},{"key":"7085_CR4","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/jcm8060860","volume":"8","author":"AK M\u00fchlig","year":"2019","unstructured":"M\u00fchlig AK, Lee JY, Kemper MJ, Kronbichler A, Yang JW, Lee JM, Shin JI, Oh J (2019) Levamisole in children with idiopathic nephrotic syndrome: clinical efficacy and pathophysiological aspects. J Clin Med 8:860","journal-title":"J Clin Med"},{"key":"7085_CR5","first-page":"71","volume":"29","author":"C Fredericks","year":"2017","unstructured":"Fredericks C, Yon JR, Alex G, Morton M, Messer T, Bokhari F, Poulakidas S (2017) Levamisole-induced necrosis syndrome: presentation and management. Wounds 29:71\u201376","journal-title":"Wounds"},{"key":"7085_CR6","doi-asserted-by":"publisher","DOI":"10.5070\/D36G18R9CV","volume":"18","author":"T Pearson","year":"2012","unstructured":"Pearson T, Bremmer M, Cohen J, Driscoll M (2012) Vasculopathy related to cocaine adulterated with levamisole: a review of the literature. Dermatol Online J 18:1","journal-title":"Dermatol Online J"},{"key":"7085_CR7","first-page":"1057","volume":"14","author":"A Bagga","year":"2000","unstructured":"Bagga A, Hari P (2000) Levamisole-induced vasculitis. Pediatr Nephrol 14:1057\u20131058","journal-title":"Pediatr Nephrol"},{"key":"7085_CR8","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1046\/j.1365-2133.1999.02833.x","volume":"140","author":"F Rongioletti","year":"1999","unstructured":"Rongioletti F, Ghio L, Ginevri F, Bleidl D, Rinaldi S, Edefonti A, Gambini C, Rizzoni G, Rebora A (1999) Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 140:948\u2013951","journal-title":"Br J Dermatol"},{"key":"7085_CR9","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s004670050753","volume":"13","author":"G Barbano","year":"1999","unstructured":"Barbano G, Ginevri F, Ghiggeri GM, Gusmano R (1999) Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome. Pediatr Nephrol 13:602\u2013603","journal-title":"Pediatr Nephrol"},{"key":"7085_CR10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3390\/medicina58050650","volume":"58","author":"S Bernardi","year":"2022","unstructured":"Bernardi S, Innocenti S, Charbit M, Boyer O (2022) Late onset of ANCA vasculitis as a side effect of levamisole treatment in nephrotic syndrome. Medicina (Kaunas) 58:650","journal-title":"Medicina (Kaunas)"},{"key":"7085_CR11","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1007\/s00467-024-06362-0","volume":"39","author":"R Sinha","year":"2024","unstructured":"Sinha R, Sarkar S, Banerjee S, Akhtar S, Poddar S, Dasgupta D, Saha R, Sengupta J, Mandal M, Tse Y, Pahari A (2024) Antineutrophil cytoplasmic antibody in children with nephrotic syndrome treated with levamisole: a cross-sectional cohort study. Pediatr Nephrol 39:2423\u20132427","journal-title":"Pediatr Nephrol"},{"key":"7085_CR12","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s00467-020-04915-7","volume":"36","author":"L Krischock","year":"2021","unstructured":"Krischock L, Pannila P, Kennedy SE (2021) Levamisole and ANCA positivity in childhood nephrotic syndrome. Pediatr Nephrol 36:1795\u20131802","journal-title":"Pediatr Nephrol"},{"issue":"Suppl","key":"7085_CR13","first-page":"S9","volume":"5","author":"M Abraham","year":"2021","unstructured":"Abraham M, Mathew G, Deepthi RV, Agarwal I (2021) Levamisole-induced antineutrophil cytoplasmic antibody positivity in nephrotic syndrome. Asian J Pediatr Nephrol 5(Suppl):S9\u2013S10","journal-title":"Asian J Pediatr Nephrol"},{"key":"7085_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.kint.2018.10.008","volume":"95","author":"M Vivarelli","year":"2019","unstructured":"Vivarelli M, Emma F (2019) Levamisole for children with nephrotic syndrome: new evidence for the use of an \u201cold\u201d drug. Kidney Int 95:25\u201328","journal-title":"Kidney Int"},{"key":"7085_CR15","unstructured":"World Health Organization. Child growth standards. Accessed September 10, 2022. https:\/\/www.who.int\/tools\/child-growth-standards"},{"key":"7085_CR16","doi-asserted-by":"publisher","first-page":"470","DOI":"10.4103\/2230-8210.159028","volume":"19","author":"VV Khadilkar","year":"2015","unstructured":"Khadilkar VV, Khadilkar AV (2015) Revised Indian Academy of Pediatrics 2015 growth charts for height, weight and body mass index for 5\u201318-year-old Indian children. Indian J Endocrinol Metab 19:470\u2013476","journal-title":"Indian J Endocrinol Metab"},{"key":"7085_CR17","doi-asserted-by":"publisher","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","volume":"140","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM, Subcommittee on Screening and Management of High Blood Pressure in Children (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140:e20171904","journal-title":"Pediatrics"},{"key":"7085_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"7085_CR19","volume":"11","author":"NG Larkins","year":"2024","unstructured":"Larkins NG, Hahn D, Liu ID, Willis NS, Craig JC, Hodson EM (2024) Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. Cochrane Database Syst Rev 11:CD002290","journal-title":"Cochrane Database Syst Rev"},{"key":"7085_CR20","doi-asserted-by":"publisher","first-page":"7388799","DOI":"10.1155\/2024\/7388799","volume":"2024","author":"M Osorio","year":"2024","unstructured":"Osorio M, Vel\u00e1squez I, Vargas R, Vanegas-Garc\u00eda A, Rojas M, V\u00e1squez G, Mu\u00f1oz-Vahos C (2024) NETosis secondary to the use of levamisole-adulterated cocaine: A likely underlying mechanism of vasculopathy. J Toxicol 2024:7388799","journal-title":"J Toxicol"},{"key":"7085_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3109\/15563650.2012.665455","volume":"50","author":"A Larocque","year":"2012","unstructured":"Larocque A, Hoffman RS (2012) Levamisole in cocaine: unexpected news from an old acquaintance. Clin Toxicol Phila 50:231\u2013241","journal-title":"Clin Toxicol Phila"},{"key":"7085_CR22","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1097\/CM9.0000000000000539","volume":"132","author":"CH Weng","year":"2019","unstructured":"Weng CH, Liu ZC (2019) Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Chin Med J (Engl) 132:2848\u20132855","journal-title":"Chin Med J (Engl)"},{"key":"7085_CR23","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.3390\/jcm13175116","volume":"13","author":"L Iorio","year":"2024","unstructured":"Iorio L, Davanzo F, Cazzador D, Codirenzi M, Fiorin E, Zanatta E, Nicolai P, Doria A, Padoan R (2024) Cocaine- and levamisole-induced vasculitis: defining the spectrum of autoimmune manifestations. J Clin Med 13:5116","journal-title":"J Clin Med"},{"key":"7085_CR24","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1002\/art.30590","volume":"63","author":"J Graf","year":"2011","unstructured":"Graf J, Lynch K, Yeh CL, Tarter L, Richman N, Nguyen T, Kral A, Dominy S, Imboden J (2011) Purpura, cutaneous necrosis, and antineutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine. Arthritis Rheum 63:3998\u20134001","journal-title":"Arthritis Rheum"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-07085-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-07085-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-07085-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T09:12:40Z","timestamp":1772442760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-07085-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7085"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-07085-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institute Ethics Committee, All India Institute of Medical Sciences, New Delhi (Supplementary Material S1). Written informed consent was taken from all the parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent"}},{"value":"All the authors declared no competing interests or financial disclosures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}